ʻO ke kāʻei a me ke alanui: Hui pū, Harmony a Win-Win
huahana

Nutraceutical

  • Diosmin CAS:520-27-4 Mea Hoʻolako Mea Hana

    Diosmin CAS:520-27-4 Mea Hoʻolako Mea Hana

    ʻO Diosmin he disaccharide derivative nona ka diosmetin i pani ʻia e kahi moiety 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl ma ke kūlana 7 ma o ka pilina glycosidic.He kuleana ko ia ma ke ʻano he antioxidant a he anti-inflammatory agent.He glycosyloxyflavone ia, he rutinoside, he disaccharide derivative, he monomethoxyflavone a me kahi dihydroxyflavanone.Loaʻa ia mai kahi diosmetin.

  • Liraglutide CAS:204656-20-2 Mea Hoʻolako Mea Hana

    Liraglutide CAS:204656-20-2 Mea Hoʻolako Mea Hana

    ʻO Liraglutide, he lipopeptide a me ka polypeptide, he mea like ia o ke kanaka GLP-1 kahi i hoʻololi ʻia ai ke koena lysine ma ke kūlana 27 e arginine a me kahi hui hexadecanoyl i hoʻopili ʻia i ke koena lysine ma o ka glutamic acid spacer.Hoʻohana ʻia ia me ka ʻai a me ka hoʻomaʻamaʻa e hoʻomaikaʻi i ka mana glycemic i nā pākeke me ka maʻi diabetes type 2.Hana ʻo Liraglutide ma ke ʻano he glucagon-like peptide-1 receptor agonist a lawelawe ma ke ʻano he neuroprotective agent.

  • TUDCA CAS:14605-22-2 Mea Hoʻolako Mea Hana

    TUDCA CAS:14605-22-2 Mea Hoʻolako Mea Hana

    ʻO Tauroursodeoxycholic acid (TUDCA) he waika bile hydrophilic i hoʻohui ʻia i loko o nā hepatocytes e ka hui ʻana o ka ursodeoxycholic acid (UDCA) me ka amino acid taurine.ʻO UDCA, ka mea i hana ʻia e ka maʻi bacteria, ua ʻae ʻia ʻo FDA ma ʻAmelika no ka mālama ʻana i kekahi mau maʻi ate cholestatic.Hana nā kānaka i ka TUDCA i kekahi ʻano, akā loaʻa ia i ka nui o ka nui i loko o ka bile o nā bea.ʻO TUDCA kahi mea hoʻokae maʻamau o ke koʻikoʻi endoplasmic reticulum (ER).

  • Carnitine HCL CAS:6645-46-1 Mea Hoʻolako Mea Hana

    Carnitine HCL CAS:6645-46-1 Mea Hoʻolako Mea Hana

    Carnitine HCLhe amino acid ka mea e pāʻani ai i ke kaʻina hana momona o ke kino.Lawe ʻo L-Carnitine i nā waikawa momona i ka mitochondria, kahi i puhi ʻia ai lākou e like me ka wahie.Hiki maoli kēia amino acid, ʻoiai hiki ke biosynthesized mai ʻelua mau mea ʻē aʻe.Ma waho aʻe o ka loaʻa ʻana i loko o kahi ākea o nā meaʻai, loaʻa pū kekahi ma ke ʻano he meaʻai meaʻai.

  • Pioglitazone HCL CAS:112529-15-4 Mea Hoʻolako Mea Hana

    Pioglitazone HCL CAS:112529-15-4 Mea Hoʻolako Mea Hana

    ʻO ka Pioglitazone hydrochloride he lāʻau antidiabetic waha i hoʻohana ʻia i ka mālama ʻana i ka maʻi maʻi type 2 (ʻike pū ʻia ʻo non-insulin-dependent diabetes mellitus (NIDDM) a i ʻole ka maʻi diabetes kanaka makua. he haʻahaʻa haʻahaʻa o ka ʻona o ka hepatic a me ka haʻahaʻa haʻahaʻa no ka launa pū ʻana i ka lāʻau.

  • Solifenacin Succinate CAS:242478-38-2 Mea Hoʻolako Mea Hana

    Solifenacin Succinate CAS:242478-38-2 Mea Hoʻolako Mea Hana

    ʻO Solifenacin succinate kahi lāʻau antimuscarinic i hoʻohana ʻia no ka mālama ʻana i ka ʻōpū overactive e hōʻike ana i nā hōʻailona o ka pinepine, wikiwiki, a i ʻole incontinence.Ua hoʻokomo ʻia nā mea loaʻa M3 i nā ʻokiʻoki ʻana o ka ʻiʻo maʻemaʻe o ka ʻōpū, a ua manaʻo ʻia hoʻi nā mea loaʻa M2 e pāʻani i kahi kuleana ma muli o ko lākou mana i ka ʻiʻo detrusor.

  • N-Acetyl-L-Alanine CAS:97-69-8 Mea Hoʻolako Mea Hana

    N-Acetyl-L-Alanine CAS:97-69-8 Mea Hoʻolako Mea Hana

    ʻO ka waikawa N-acetyl-L-amino he L-alanine kahi i hoʻololi ʻia ai kekahi o nā hydrogens i hoʻopili ʻia i ka nitrogen e kahi hui acetyl. N-Acetyl-L-alanine/ 2-Acetylaminopropionic acid he crystalline solid i hoʻohana ʻia i ka immunodominant mea hoʻoholo o ka ʻilikai ʻakika antigen mai ka kānana moʻomeheu o ke kaʻina kanaka o Staph aureus.

  • Flutamide CAS:13311-84-7 Mea Hoʻolako Mea Hana

    Flutamide CAS:13311-84-7 Mea Hoʻolako Mea Hana

    ʻO Flutamide kahi amide monocarboxylic acid a he lālā o (trifluoromethyl) benzenes.Loaʻa iā ia kahi hana ma ke ʻano he antagonist androgen a me ka antineoplastic agent.Flutamide kahi ʻano synthetic, non-steroidal antiandrogen i hoʻohana nui ʻia no ka mālama ʻana i ka maʻi prostate.He ʻano ʻano toluidine derivative a me kahi antiandrogen nonsteroidal me kahi ʻano like o ka bicalutamide a me ka nilutamide.

  • Setmelanotide CAS:920014-72-8 Mea Hoʻolako Mea Hana

    Setmelanotide CAS:920014-72-8 Mea Hoʻolako Mea Hana

    ʻO Setmelanotide kahi melanocortin 4 receptor (MC4R) agonist, e hana ana i ke kanaka a me ka iole MC4R;ʻOkoʻa paha ke ʻano o ka hoʻoulu ʻana o MC4R e setmelanotide mai nā ligands maoli a me nā agonists synthetic o ka hanauna mua;Hiki i ka hoʻonohonoho ʻana i ka melanotide ke pāʻani ma ke kūʻē ʻana i nā neurotransmitters e kū maoli ana a keʻakeʻa i ka hoʻāla ʻana o MC4R;Ua hōʻoia ʻia he hopena maikaʻi ʻo Setmelanotide i ka mālama ʻana i ka momona a ua hōʻea i ka pae hope o ka pae 3.

  • Arginine HCL CAS:1119-34-2 Mea Hoʻolako Mea Hana

    Arginine HCL CAS:1119-34-2 Mea Hoʻolako Mea Hana

    Arginine HCLhe ʻano paʻakai o L-Arginine, kahi i hoʻohui ʻia ai ka waika hydrochloric e hoʻoikaika i ka paʻa a me ka solubility.ʻO Arginine hydrochloride kahi waikawa L-alpha-amino.He waikawa amino koʻikoʻi i hoʻoikaika kino i ke ʻano L.Hiki i ka L-Arginine ke hoʻohaʻahaʻa i ke koko, hōʻemi i nā hōʻailona o ka angina a me PAD, a me ka mālama ʻana i ka erectile dysfunction ma muli o ke kumu kino.

  • L-Carnitine Fumarate CAS:90471-79-7 Mea Hoʻolako Mea Hana

    L-Carnitine Fumarate CAS:90471-79-7 Mea Hoʻolako Mea Hana

    ʻO ka L-Carnitine fumarate kahi ʻano paʻa o L-carnitine, maʻalahi e hoʻomoʻi i ka wai e like me ka pauka keʻokeʻo a i ʻole ka pauka crystalline, hiki ke hoʻoheheʻe ʻia i ka wai. a me nā halo.Hoʻohana nui ʻia ia ma ke ʻano he meaʻai.

  • Linagliptin CAS:668270-12-0 Mea Hoʻolako Mea Hana

    Linagliptin CAS:668270-12-0 Mea Hoʻolako Mea Hana

    ʻO Linagliptin (nā inoa kālepa ʻo Tradjenta a me Trajetna) he mea hoʻopale o dipeptidyl peptidase-4 (DPP-4) i ʻae ʻia e ka US FDA i Mei 2011 no ka mālama ʻana i ka maʻi maʻi type 2 me ka ʻai a me ka hoʻoikaika kino.Ua wehewehe ʻia ʻo Linagliptin (BI-1356) ma ke ʻano he mea koho nui loa, lohi-off rate a me ka hana lōʻihi o DPP-4.Ua kū mai ʻo Linagliptin mai ka hoʻoikaika ʻana o ka xanthine-based DPP-4 inhibitors me ke alakaʻi mua i ʻike ʻia mai kahi hoʻolaha HTS.